GLP-1 drugs can produce major weight loss, but their wider impact will depend on affordable treatment and appropriate support.
Articles on Tirzepatide
Displaying all articles
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in those taking Ozempic, Wegovy and Mounjaro.
Weight doesn’t tell us the whole story about a person’s risk for poor health.
A new study shows drugs such as Ozempic come with a small but increased risk of a condition known as an ‘eye stroke’.
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
Mounjaro leads to weight loss, which can help patients with sleep apnoea.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares with Ozempic.
The weight loss drug is even more effective than Wegovy.
Ozempic generated A$21 billion of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?
People who are obese, as well as those who are overweight and have weight-related issues, may soon be able to ask their doctor for a prescription.
In trials, Mounjaro was shown to be more effective than Ozempic in managing type 2 diabetes.
Top contributors
-
Head of the Translational Nanomedicine & Biotherapeutics Group and Senior Research Fellow, Adelaide University
-
Clinical Associate Professor, Diabetes and Endocrinology, Aston University
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Honorary Associate Professor, University of Leicester
-
Senior Lecturer, Pharmacy, Aston University
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Professor of Health Service Operations, School of Pharmacy & Medical Sciences, University of Bradford
-
Accredited Pharmacist, PhD Student, Adelaide University
-
Clinical Epidemiologist, Washington University in St. Louis
-
Research Program Manager, Let's Yarn About Sleep, Thompson Institute, University of the Sunshine Coast
-
Professor of Sleep Health, University of the Sunshine Coast
-
Associate Professor of Physiology and Medical Education, Anglia Ruskin University
-
Ulla and Ingemar Dahlberg Professor in Vision Science, Research Group Leader, Karolinska Institutet